Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05203445
What this trial is testing

Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07560475
What this trial is testing

Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients

Who this might be right for
HER2positiveAdvanced Breast CancerHER2 + Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Large-scale testing (Phase 3)Study completedNCT02511639
What this trial is testing

Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer Metastatic
Istituto Oncologico Veneto IRCCS 110
Not applicableLooking for participantsNCT06483477
What this trial is testing

Dermatitis During Adjuvant Irradiation for BREAst Cancer:

Who this might be right for
Breast Cancer Female
University Hospital Schleswig-Holstein 268
Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Not applicableStudy completedNCT00885612
What this trial is testing

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Who this might be right for
Breast Cancer
AstraZeneca 1,114
Not applicableStudy completedNCT00991653
What this trial is testing

Weight Fluctuation After Breast Cancer Treatment

Who this might be right for
Breast CancerWeight Gain
The Royal Bournemouth Hospital 250
Early research (Phase 1)Study completedNCT01077453
What this trial is testing

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

Who this might be right for
Healthy, no Evidence of DiseaseLobular Breast Carcinoma in Situ
National Cancer Institute (NCI) 112
Not applicableStudy completedNCT04257045
What this trial is testing

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives

Who this might be right for
Breast CarcinomaDeleterious CDH1 Gene MutationDeleterious DICER1 Gene Mutation+6 more
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)UnknownNCT02511301
What this trial is testing

Circadian Thermal Sensing to Detect Breast Disease

Who this might be right for
Early-Stage Breast Carcinoma
Cyrcadia Health 173
Testing effectiveness (Phase 2)UnknownNCT02349581
What this trial is testing

Ultrasound Guided Pectoral Nerves Blockade for Persistent Pain After Breast Cancer Surgery

Who this might be right for
Persistent Pain After Breast Cancer Surgery
Rigshospitalet, Denmark 6
Large-scale testing (Phase 3)Study completedNCT04957212
What this trial is testing

Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Cinnagen 214
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Not applicableUnknownNCT00530569
What this trial is testing

Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy

Who this might be right for
Breast Cancer
Alberta Health services 60
Not applicableLooking for participantsNCT01521741
What this trial is testing

Prospective Screening for Breast Cancer-related Lymphedema

Who this might be right for
Lymphedema
Massachusetts General Hospital 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT07340541
What this trial is testing

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Who this might be right for
Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer+2 more
UNC Lineberger Comprehensive Cancer Center 700
Large-scale testing (Phase 3)Study completedNCT00524849
What this trial is testing

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Who this might be right for
Metastatic Breast CancerBone Metastases
Fudan University 60
Not applicableStudy completedNCT00321048
What this trial is testing

Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC

Who this might be right for
Breast NeoplasmsCarcinoma, DuctalAdenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Not applicableStudy completedNCT06463626
What this trial is testing

Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

Who this might be right for
Hormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Novartis 121
Testing effectiveness (Phase 2)Study completedNCT04588935
What this trial is testing

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

Who this might be right for
Women With Breast Cancer
State Institution "Republican Scientific and Practical Center" Cardiology, Belarus 100
Next Page